Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury
Alpha Cognition Inc. (ACOG)
Company Research
Source: Business Wire
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to announce the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,589,099 on March 31, 2026. The patent, titled “ALPHA-1062 for treating Traumatic Brain Injury,” includes claims covering methods of treating both confirmed and suspected traumatic brain injury (TBI) using ALPHA-1062.This newly issued patent strengthens Alpha Cognition’s intellectual property portfolio and complements existing patents supporting both ALPHA-1062 and ZUNVEYL®. The patent provides protection through 2045, aligning with the Company’s long-term strategy to maximize the value and lifecycle of its lead assets.“This patent marks an important milestone in expanding our platform beyond Alzheimer’s disease,” said Michael McF
Show less
Read more
Impact Snapshot
Event Time:
ACOG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACOG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACOG alerts
High impacting Alpha Cognition Inc. news events
Weekly update
A roundup of the hottest topics
ACOG
News
- Alpha Cognition (ACOG) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ACOG&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" MarketBeat
- Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury [Yahoo! Finance]Yahoo! Finance
- Alpha Cognition (ACOG) Q4 2025 Earnings Transcript [Yahoo! Finance]Yahoo! Finance
- Alpha Cognition Inc. (ACOG) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Alpha Cognition Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
ACOG
Earnings
- 3/26/26 - Miss
ACOG
Sec Filings
- 3/31/26 - Form 10-K
- 3/31/26 - Form 4
- 3/27/26 - Form 8-K
- ACOG's page on the SEC website